PERSPECTA

News from every angle

Back to headlines

CVRx stock rebounds following Humana's Medicare policy for Barostim

CVRx shares have seen a rebound after Humana issued a new Medicare policy covering the company's Barostim device.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.